0001608403-14-000001.txt : 20140516 0001608403-14-000001.hdr.sgml : 20140516 20140516162437 ACCESSION NUMBER: 0001608403-14-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20140516 DATE AS OF CHANGE: 20140516 EFFECTIVENESS DATE: 20140516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VELIUS, LLC CENTRAL INDEX KEY: 0001608403 IRS NUMBER: 113626249 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-217563 FILM NUMBER: 14851876 BUSINESS ADDRESS: STREET 1: 15 BARSTOW ROAD CITY: GREAT NECK STATE: NY ZIP: 11021 BUSINESS PHONE: 516-482-8050 MAIL ADDRESS: STREET 1: 15 BARSTOW ROAD CITY: GREAT NECK STATE: NY ZIP: 11021 D 1 primary_doc.xml X0707 D LIVE 0001608403 VELIUS, LLC 15 BARSTOW ROAD GREAT NECK NY NEW YORK 11021 516-482-8050 DELAWARE Red Rock Laboratories, LLC Scarguard Labs, LLC None Limited Liability Company true Joel Roy Studin 15 BARSTOW ROAD Great Neck NY NEW YORK 11021 Executive Officer Director Joel R. Studin, M.D. is the Chief Executive Officer and a manager of the Issuer. Andrew Bart Oxenhorn 15 BARSTOW ROAD Great Neck NY NEW YORK 11021 Director Andrew B.Oxenhorn is a manager of the Issuer. Lester Rosenkrantz 15 BARSTOW ROAD Great Neck NY NEW YORK 11021 Director Lester Rosenkrantz is a manager of the Issuer. William Alan Landman 15 BARSTOW ROAD Great Neck NY NEW YORK 11021 Director William A. Landman is a manager of the Issuer. Thomas Joseph Jennings 15 BARSTOW ROAD Great Neck NY NEW YORK 11021 Director Thomas J. Jennings is a manager of the Issuer. James Edward Dunn 15 BARSTOW ROAD Great Neck NY NEW YORK 11021 Executive Officer James E. Dunn is the Executive Vice President of Sales of the Issuer. Peter Yarnton Mills 15 BARSTOW ROAD Great Neck NY NEW YORK 11021 Executive Officer Peter Y. Mills is the Chief Financial Officer of the Issuer. Pharmaceuticals $1,000,001 - $5,000,000 06b false true false true false 50000 7000000 0 7000000 false 0 0 0 280000 true If the full amount of the offering is raised, this loan will be paid off using the gross proceeds of the offering. false VELIUS, LLC Joel R. Studin Joel R. Studin, M.D. Chief Executive Officer 2014-05-15